J Cancer 2018; 9(20):3669-3675. doi:10.7150/jca.27183 This issue Cite

Research Paper

Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs

Yansong Pu1*, Tao Zhang1*, Jianhua Wang1✉, Zhijun Mao1, Baojun Duan2, Yanbin Long1, Fei Xue1, Dong Liu1, Sida Liu1, Zengzhan Gao1

1. The Second Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.
2. Department of Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.
*Dr Yansong Pu and Dr Tao Zhang contributed equally to this work.

Citation:
Pu Y, Zhang T, Wang J, Mao Z, Duan B, Long Y, Xue F, Liu D, Liu S, Gao Z. Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs. J Cancer 2018; 9(20):3669-3675. doi:10.7150/jca.27183. https://www.jcancer.org/v09p3669.htm
Other styles

File import instruction

Abstract

Accumulating studies confirmed that luteolin, a common dietary flavonoid which is widely distributed in plants and has diverse beneficial biological function, including anti-oxidant, anti-inflammation and anticancer properties. However, the detail mechanisms of luteolin on GC are poorly understood. Here, we investigated the anticancer effect of luteolin in GC cells in vitro and in vivo. Luteolin reduced the cell viability in a time and dose-dependent manner. Luteolin significantly inhibited cell cycle progress, colony formation, proliferation, migration, invasion and promoted apoptosis in vitro and in vivo. Luteolin also regulated these biological effects associated regulators. Mechanically, luteolin treatment regulated Notch1, PI3K, AKT, mTOR, ERK, STAT3 and P38 signaling pathways and modulated a series of miRNAs expression. These findings provide novel insight into the molecular function of luteolin which suggest its potential as a therapeutic agent for human GC.

Keywords: Luteolin, gastric cancer, EMT, prognosis, metastasis


Citation styles

APA
Pu, Y., Zhang, T., Wang, J., Mao, Z., Duan, B., Long, Y., Xue, F., Liu, D., Liu, S., Gao, Z. (2018). Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs. Journal of Cancer, 9(20), 3669-3675. https://doi.org/10.7150/jca.27183.

ACS
Pu, Y.; Zhang, T.; Wang, J.; Mao, Z.; Duan, B.; Long, Y.; Xue, F.; Liu, D.; Liu, S.; Gao, Z. Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs. J. Cancer 2018, 9 (20), 3669-3675. DOI: 10.7150/jca.27183.

NLM
Pu Y, Zhang T, Wang J, Mao Z, Duan B, Long Y, Xue F, Liu D, Liu S, Gao Z. Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs. J Cancer 2018; 9(20):3669-3675. doi:10.7150/jca.27183. https://www.jcancer.org/v09p3669.htm

CSE
Pu Y, Zhang T, Wang J, Mao Z, Duan B, Long Y, Xue F, Liu D, Liu S, Gao Z. 2018. Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs. J Cancer. 9(20):3669-3675.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image